Nephron CEO Ready to Get South Carolina Moving Again
Governor Henry McMaster announced Nephron Pharmaceuticals Corporation CEO and owner Lou Kennedy as a member of the state’s coordinated COVID-19 advisory and recovery team. The team, a part of accelerateSC, will make recommendations regarding economic revitalization plans in the aftermath of the global COVID-19 pandemic that has closed public and private sector institutions.
“I am ready to work with Governor McMaster to get South Carolina moving again,” said Kennedy. “We will strike the right balance between saving lives and saving livelihoods, and serve as a model for our neighbors.”
Nephron develops and produces safe, affordable generic inhalation solutions and suspension products that can be used to treat symptoms of COVID19. In addition, the company operates an industry-leading 503B Outsourcing Facility division which produces pre-filled sterile syringes and IV bags for hospitals across America, in an effort to alleviate their drug shortage needs.
Recognizing the impact of COVID-19’s impact to South Carolina’s economy, Gov. McMaster created accelerateSC, a coordinated economic revitalization plan involving small and large business leaders, healthcare professionals, local government officials, and education professionals.
The plan consists of five components of analysis and effort: Response, Protection, Governance, Resources, and Information. James Burns, a partner at the law firm of Nelson, Mullins, Riley and Scarborough, will serve as accelerateSC’s executive director. Burns and the rest of the membership are serving in a voluntary capacity. For further information about accelerateSC and its members, visit the governor’s website here.
Gov. McMaster and Lt. Governor Pamela Evette will attend and lead the first meeting of accelerateSC on Thursday of this week. Additional details will be announced at a later date.